D. E. Shaw & Co. Inc. Raises Stake in Cardlytics, Inc. (NASDAQ:CDLX)

D. E. Shaw & Co. Inc. grew its position in Cardlytics, Inc. (NASDAQ:CDLX - Free Report) by 97.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,131,505 shares of the company's stock after purchasing an additional 558,235 shares during the quarter. D. E. Shaw & Co. Inc. owned approximately 2.23% of Cardlytics worth $4,198,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Cubist Systematic Strategies LLC acquired a new stake in shares of Cardlytics in the 4th quarter valued at $241,000. Bridgeway Capital Management LLC acquired a new stake in shares of Cardlytics in the 4th quarter valued at $416,000. BNP Paribas Financial Markets raised its holdings in shares of Cardlytics by 112.2% in the 4th quarter. BNP Paribas Financial Markets now owns 41,907 shares of the company's stock valued at $155,000 after purchasing an additional 22,162 shares in the last quarter. Acorn Financial Advisory Services Inc. ADV raised its holdings in shares of Cardlytics by 49.5% in the 4th quarter. Acorn Financial Advisory Services Inc. ADV now owns 245,806 shares of the company's stock valued at $912,000 after purchasing an additional 81,397 shares in the last quarter. Finally, Northern Trust Corp raised its holdings in shares of Cardlytics by 8.0% in the 4th quarter. Northern Trust Corp now owns 373,770 shares of the company's stock valued at $1,387,000 after purchasing an additional 27,536 shares in the last quarter. 68.10% of the stock is currently owned by institutional investors and hedge funds.

Cardlytics Stock Down 2.6%

NASDAQ:CDLX traded down $0.05 during midday trading on Friday, hitting $1.84. 364,304 shares of the company were exchanged, compared to its average volume of 987,415. The company has a fifty day simple moving average of $1.77 and a 200 day simple moving average of $2.83. Cardlytics, Inc. has a fifty-two week low of $1.22 and a fifty-two week high of $9.85. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. The company has a market capitalization of $96.60 million, a PE ratio of -0.30 and a beta of 1.30.

Wall Street Analyst Weigh In

CDLX has been the topic of a number of analyst reports. Lake Street Capital reduced their price objective on shares of Cardlytics from $3.00 to $2.50 and set a "hold" rating on the stock in a report on Thursday, May 8th. Needham & Company LLC reiterated a "hold" rating on shares of Cardlytics in a research note on Thursday, March 13th. Finally, Evercore ISI cut their price target on shares of Cardlytics from $4.00 to $3.00 and set an "in-line" rating on the stock in a research note on Thursday, March 13th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $5.20.

Cardlytics Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.